The movement to cap insulin prices for diabetes patients grew larger in the United States this week. Consumer advocates in North Dakota say the news is welcome as state and federal policies evolve to limit skyrocketing costs for the drug. On Monday, Sanofi became the latest manufacturer to implement insulin price cuts, capping out-of-pocket expenses at $35 a month. ...